What is DNOW's health score?

DNOW Inc. (DNOW) has a TradeApes health score of 62 out of 100, rated Healthy. This composite score evaluates financial strength, operating trends, valuation, capital allocation, and risk factors.

What is DNOW's estimated fair value?

Based on our 5-year discounted cash flow model, DNOW Inc.'s estimated fair value is $4.78 per share, representing a -64.6% downside from the current price. This is a model estimate, not a price target or investment recommendation.

Is DNOW undervalued or overvalued?

Our model currently rates DNOW as Overvalued. This assessment combines health metrics, valuation multiples, and market sentiment. Individual investors should conduct their own due diligence.

Crunching the numbers for DNOW... Refresh in a moment for the full analysis.

DNOW Inc. (DNOW)

Technology Overvalued medium healthy

$13.5

Updated: 2026-06-05

TradeApes Score

Financial Strength

80 Strong

Operating Trend

55 Mixed

Relative Value

50 Mixed

Capital Allocation

55 Mixed

Risk

70 Healthy

Est. Fair Value $4.78

DCF Upside -64.6%

Sector Rank #4961 of 7740

Key Findings

+ Net cash position — more cash on hand than total debt

Unlock Full Report →

− FCF deteriorating — free cash flow down more than 25% year over year

Unlock Full Report →

4 free score cards remaining

TradeApes provides financial data, analytics, and research tools. TradeApes is not a registered investment adviser, broker-dealer, or tax advisor. The information presented is for educational and informational purposes only and does not constitute investment, financial, or tax advice.

11 sector-leading stocks delivered to your inbox every Sunday. Free.

No spam. Unsubscribe anytime.